RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules

Virology

Volumn 391, Issue 2, 2009, Pages 162-170

  Hashimoto, Koichi ^a   Ishibashi, Kei ^a   Ishioka, Ken ^a   Zhao, Dongchi ^a   Sato, Masatoki ^a   Ohara, Shinichiro ^a   Abe, Yusaku ^a   Kawasaki, Yukihiko ^a   Sato, Yuka ^a   Yokota, Shin ichi ^b   Fujii, Nobuhiro ^b   Peebles Jr , Ray Stokes ^c   Hosoya, Mitsuaki ^a   Suzutani, Tatsuo ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

IFN; JAK STAT; RSV; siRNA; SOCS

Indexed keywords

INTERFERON; JANUS KINASE; MESSENGER RNA; SMALL INTERFERING RNA; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; FEEDBACK SYSTEM; HEP 2 CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; INNATE IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RNA INTERFERENCE; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS IMMUNITY; VIRUS REPLICATION;

CELL LINE; CYTOKINES; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; RESPIRATORY SYNCYTIAL VIRUSES; RNA, SMALL INTERFERING; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION; VIRUS REPLICATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 68749090768     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.06.026     Document Type: Article

References (53)

1. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M., Kay T.W., Nicola N.A., Hertzog P.J., Metcalf D., and Hilton D.J. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98 5 (1999) 597-608
2. Baetz A., Frey M., Heeg K., and Dalpke A.H. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J. Biol. Chem. 279 52 (2004) 54708-54715
3. Bode J.G., Ludwig S., Ehrhardt C., Albrecht U., Erhardt A., Schaper F., Heinrich P.C., and Haussinger D. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. Faseb J. 17 3 (2003) 488-490
4. Bossert B., and Conzelmann K.K. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol. 76 9 (2002) 4287-4293
5. Brand S., Zitzmann K., Dambacher J., Beigel F., Olszak T., Vlotides G., Eichhorst S.T., Goke B., Diepolder H., and Auernhammer C.J. SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Biochem. Biophys. Res. Commun. 331 2 (2005) 543-548
6. Brierley M.M., and Fish E.N. Functional relevance of the conserved DNA-binding domain of STAT2. J. Biol. Chem. 280 13 (2005) 13029-13036
7. Bromberg J.F., Horvath C.M., Wen Z., Schreiber R.D., and Darnell Jr. J.E. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 93 15 (1996) 7673-7678
8. Dalpke A., and Heeg K. Suppressors of cytokine signaling proteins in innate and adaptive immune responses. Arch. Immunol. Ther. Exp. (Warsz). 51 2 (2003) 91-103
9. Dalpke A.H., Opper S., Zimmermann S., and Heeg K. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166 12 (2001) 7082-7089
10. Decker T., Stockinger S., Karaghiosoff M., Muller M., and Kovarik P. IFNs and STATs in innate immunity to microorganisms. J. Clin. Invest. 109 10 (2002) 1271-1277
11. Durbin J.E., Johnson T.R., Durbin R.K., Mertz S.E., Morotti R.A., Peebles R.S., and Graham B.S. The role of IFN in respiratory syncytial virus pathogenesis. J. Immunol. 168 6 (2002) 2944-2952
12. Erickson-Miller C.L., Pelus L.M., and Lord K.A. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation. Stem Cells 18 5 (2000) 366-373
13. Falsey A.R. Respiratory syncytial virus infection in elderly and high-risk adults. Exp. Lung Res. 31 Suppl. 1 (2005) 77
14. Gotoh B., Komatsu T., Takeuchi K., and Yokoo J. Paramyxovirus accessory proteins as interferon antagonists. Microbiol. Immunol. 45 12 (2001) 787-800
15. Graham B.S., Perkins M.D., Wright P.F., and Karzon D.T. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26 2 (1988) 153-162
16. Hansen J.A., Lindberg K., Hilton D.J., Nielsen J.H., and Billestrup N. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol. Endocrinol. 13 11 (1999) 1832-1843
17. Hashimoto K., Durbin J.E., Zhou W., Collins R.D., Ho S.B., Kolls J.K., Dubin P.J., Sheller J.R., Goleniewska K., O'Neal J.F., Olson S.J., Mitchell D., Graham B.S., and Peebles Jr. R.S. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J. Allergy Clin. Immunol. 116 3 (2005) 550-557
18. Horvath C.M. Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur. J. Biochem. 271 23-24 (2004) 4621-4628
19. Johnson T.R., Mertz S.E., Gitiban N., Hammond S., Legallo R., Durbin R.K., and Durbin J.E. Role for innate IFNs in determining respiratory syncytial virus immunopathology. J. Immunol. 174 11 (2005) 7234-7241
20. Kawaguchi T., Yoshida T., Harada M., Hisamoto T., Nagao Y., Ide T., Taniguchi E., Kumemura H., Hanada S., Maeyama M., Baba S., Koga H., Kumashiro R., Ueno T., Ogata H., Yoshimura A., and Sata M. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am. J. Pathol. 165 5 (2004) 1499-1508
21. Krebs D.L., and Hilton D.J. SOCS: physiological suppressors of cytokine signaling. J. Cell. Sci. 113 Pt 16 (2000) 2813-2819
22. Krebs D.L., and Hilton D.J. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19 5 (2001) 378-387
23. Lo M.S., Brazas R.M., and Holtzman M.J. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79 14 (2005) 9315-9319
24. Naito Y., Yamada T., Ui-Tei K., Morishita S., and Saigo K. siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic. Acids Res. 32 Web Server issue (2004) W124-W129
25. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., and Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature 387 6636 (1997) 924-929
26. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K., Akira S., Yamanishi K., Kawase I., Nakanishi K., and Kishimoto T. SOCS-1 participates in negative regulation of LPS responses. Immunity 17 5 (2002) 677-687
27. Narazaki M., Fujimoto M., Matsumoto T., Morita Y., Saito H., Kajita T., Yoshizaki K., Naka T., and Kishimoto T. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc. Natl. Acad. Sci. U.S.A. 95 22 (1998) 13130-13134
28. Nicholson S.E., De Souza D., Fabri L.J., Corbin J., Willson T.A., Zhang J.G., Silva A., Asimakis M., Farley A., Nash A.D., Metcalf D., Hilton D.J., Nicola N.A., and Baca M. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl. Acad. Sci. U.S.A. 97 12 (2000) 6493-6498
29. Nicola N.A., Nicholson S.E., Metcalf D., Zhang J.G., Baca M., Farley A., Willson T.A., Starr R., Alexander W., and Hilton D.J. Negative regulation of cytokine signaling by the SOCS proteins. Cold Spring Harbor Symp. Quant. Biol. 64 (1999) 397-404
30. Oshansky C.M., Krunkosky T.M., Barber J., Jones L.P., and Tripp R.A. Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. Viral Immunol. 22 3 (2009) 147-161
31. Ramaswamy M., Shi L., Monick M.M., Hunninghake G.W., and Look D.C. Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 30 6 (2004) 893-900
32. Schaefer T.M., Fahey J.V., Wright J.A., and Wira C.R. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J. Immunol. 174 2 (2005) 992-1002
33. Schwarze J., Cieslewicz G., Joetham A., Ikemura T., Makela M.J., Dakhama A., Shultz L.D., Lamers M.C., and Gelfand E.W. Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am. J. Respir. Crit. Care Med. 162 2 Pt 1 (2000) 380-386
34. Shen L., Evel-Kabler K., Strube R., and Chen S.Y. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat. Biotechnol. 22 12 (2004) 1546-1553
35. Sigurs N., Bjarnason R., Sigurbergsson F., and Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161 5 (2000) 1501-1507
36. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., and Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171 2 (2005) 137-141
37. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., and Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5 9 (2003) 834-839
38. Spann K.M., Tran K.C., Chi B., Rabin R.L., and Collins P.L. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J. Virol. 78 8 (2004) 4363-4369
39. Spann K.M., Tran K.C., and Collins P.L. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J. Virol. 79 9 (2005) 5353-5362
40. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., and Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature 387 6636 (1997) 917-921
41. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L.M., Wright A.L., and Martinez F.D. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354 9178 (1999) 541-545
42. Tayyari F., Sutton T.C., Manson H.E., and Hegele R.G. CpG-oligodeoxynucleotides inhibit RSV-enhanced allergic sensitisation in guinea pigs. Eur. Respir. J. 25 2 (2005) 295-302
43. Valarcher J.F., Furze J., Wyld S., Cook R., Conzelmann K.K., and Taylor G. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J. Virol. 77 15 (2003) 8426-8439
44. Vlotides G., Sorensen A.S., Kopp F., Zitzmann K., Cengic N., Brand S., Zachoval R., and Auernhammer C.J. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem. Biophys. Res. Commun. 320 3 (2004) 1007-1014
45. Wang Y., and Jiang H. Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression. J. Biol. Chem. 280 12 (2005) 10955-10963
46. Wu W., Hodges E., Redelius J., and Hoog C. A novel approach for evaluating the efficiency of siRNAs on protein levels in cultured cells. Nucleic. Acids Res. 32 2 (2004) e17
47. Yasukawa H., Yajima T., Duplain H., Iwatate M., Kido M., Hoshijima M., Weitzman M.D., Nakamura T., Woodard S., Xiong D., Yoshimura A., Chien K.R., and Knowlton K.U. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J. Clin. Invest. 111 4 (2003) 469-478
48. Yokota S., Yokosawa N., Okabayashi T., Suzutani T., Miura S., Jimbow K., and Fujii N. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J. Virol. 78 12 (2004) 6282-6286
49. Yokota S., Yokosawa N., Okabayashi T., Suzutani T., and Fujii N. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication. Virology 338 1 (2005) 173-181
50. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., and Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 7 (2004) 730-737
51. Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N.A., Gilbert D.J., Copeland N.G., Hara T., and Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. Embo J. 14 12 (1995) 2816-2826
52. Zhang W., Yang H., Kong X., Mohapatra S., San Juan-Vergara H., Hellermann G., Behera S., Singam R., Lockey R.F., and Mohapatra S.S. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 11 1 (2005) 56-62
53. Zhao D.C., Yan T., Li L., You S., and Zhang C. Respiratory syncytial virus inhibits interferon-alpha-inducible signaling in macrophage-like U937 cells. J. Infect. 54 4 (2007) 393-398